Heart Disease Trial, Recruiting NCT07001007 Sponsor: HJN Sverige AB/Neko Health Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07001007
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must already be taking part in the main SCAPIS 2 study at Danderyd Hospital in Stockholm, Sweden
  • You must have already had a heart ultrasound (echocardiography) examination as part of that study

Who may not be able to join:

  • People who are not able to give their own consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Professor Jonas Spaak, MD, PhD, Karolinska Institute, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden

Phone: +46703169040

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
HJN Sverige AB/Neko Health
Registry
ClinicalTrials.gov
Start date
1 July 2024
Est. completion
1 June 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Area under receiver operating curve (ROC) to predict CAD-RADS ≥2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov